AURIS MEDICAL (EARS)

[JJAAMMAANN]

Results from their other Phase 3 trial are due Q1, 2018.
There are a lot of people who are stuck in the .80's range, so this will stabilize soon and hopefully start growing legs in anticipation of the results.
I am only guessing here, but it looks like they will petition the FDA to allow the treatment to go forward based on the subgroups and the past Phase 2 studies. Wish they would have been more clear on the announcement! I have seen other drugs make the leap on failed Phase 3 studies...meaning those that didn't meet primary endpoints, but captured other promising data. Would just need to do a revision change for the primary treatments.
IMHO
Best of Luck!